Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05296512
Title Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Elizabeth K. Lee MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.